DNA to heal asthma?

A new nature medicine review is listing clinical trials targeting Toll-like receptors. These include 3 preclinical studies all using cpG-ODNs against TLR9 by Dynavax Astra-Zeneca, Coley / Sanofi-Aventis and Idera / Novartis. Lets wait and see…

CC-BY-NC Science Surf 2.10.2007, access 18.10.2025 VG Wort counter note save PDF